Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease

Citation
J. Marksteiner et al., Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer's disease, ACT NEUROP, 100(2), 2000, pp. 205-212
Citations number
37
Categorie Soggetti
Neurosciences & Behavoir
Journal title
ACTA NEUROPATHOLOGICA
ISSN journal
00016322 → ACNP
Volume
100
Issue
2
Year of publication
2000
Pages
205 - 212
Database
ISI
SICI code
0001-6322(200008)100:2<205:DOCBII>2.0.ZU;2-2
Abstract
Synapse loss is crucially involved in cognitive decline in Alzheimer's dise ase (AD). This study was performed to investigate the distribution and dens ity of chromogranin B-like immunoreactivity in the hippocampus of control c ompared to AD brain. Chromogranin B is a large precursor molecule found in large dense-core vesicles. For immunocytochemistry we used an antiserum rai sed against a synthetic peptide (PE-11) present in the chromogranin B molec ule. Chromogranin B-like immunoreactivity was concentrated in the terminal field of mossy fibers, the inner molecular layer of the dentate gyrus and i n layer II of the entorhinal cortex. In AD, chromogranin B was detected in neuritic plaques. The density of chromogranin B-like immunoreactivity was s ignificantly reduced in the inner molecular layer of the dentate gyrus and in layers II, III and V of the entorhinal cortex in AD brains. The present study demonstrates that chromogranin B is a marker for human hippocampal pa thways. It is particularly suitable for studying nerve fibers terminating a t the inner molecular layer of the dentate gyrus. It is present in neuritic plaques, and its density is reduced in a layer-specific manner.